Article Details
Retrieved on: 2021-08-31 08:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
BioPorto A/S (BioPorto) has successfully concluded an interim analysis of data from the pediatric clinical trial being conducting to evaluate The NGAL Test™ ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here